Trading

Data

Solutions

Insights

Ansun Biopharma Stock

ansunbiopharma.comHealthcareFounded: 2003Funding to Date: $165.2MM

Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics.

Buy or sell Ansun Biopharma stock Learn more about Ansun Biopharma IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Ansun Biopharma.

Register Today

Team

Management Team

Nancy Chang Ph.D

Chief Executive Officer & Chairperson of the Board

Ivy Fan

Executive

George Wang

Chief Technology Officer

Mikael Havluciyan

Chief Legal Officer & Corporate Secretary

Stanley Lewis MD

Chief Medical Officer

Board Members

Allen Chao Ph.D

Karen Liu Ph.D

Nancy Chang Ph.D

Aimin Wu

Sinopharm Healthcare Fund

Donald Payne

Michael Chao MD

Dave Chenn

Michael Chang Ph.D

Yi Shi Ph.D

Lilly Asia Ventures

Other companies like Ansun Biopharma in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Healthcare

News

Deal Street Asia 10/14/2019

Chinese biotech firm Ansun BioPharma secures $80m Series B financing

Ansun aims to drive the global Phase 3 clinical trial of its experimental anti-viral medication.

Popular Topics

Popular Topics

Ansun Biopharma Stock

Register for Details